{"gao_id": "GAO-22-104371", "published": "2021-11-16T12:00:00Z", "released": "2021-11-16T07:00:00Z", "summary": "The CARES Act requires GAO to look at the government's response to the COVID-19 pandemic, including vaccine development. Vaccines prepare the body to respond quickly to an infection and play a key role in keeping people and global communities healthy. Overall, vaccine development is still difficult, complex, and costly. But we identified 16 innovative technologies and approaches that may enhance the nation's ability to respond...", "title": "Vaccine Development: Capabilities and Challenges for Addressing Infectious Diseases", "topics": ["Clinical trials", "Infectious diseases", "Public health emergencies", "pandemics", "Vaccinations", "Genetics", "Monoclonal antibodies", "Immune system", "Health care", "Health care standards", "Medicine", "Pathogens", "Research and development", "Science and Technology", "Patient care", "Epidemics"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-22-104371", "versions": [{"title": "Highlights Page (2 pages)", "url": "https://www.gao.gov/assets/gao-22-104371-highlights.pdf"}, {"title": "Full Report (84 pages)", "url": "https://www.gao.gov/assets/gao-22-104371.pdf"}, {"title": "Accessible PDF (84 pages)", "url": "https://www.gao.gov/assets/720/717636.pdf"}]}